BML Investment Partners L.P. 13D and 13G filings for CYTEIR THERAPEUTICS INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-03-19 4:29 pm Purchase |
2024-03-18 | 13G | CYTEIR THERAPEUTICS INC CYTT |
BML Investment Partners L.P. | 3,818,464 10.600% |
348,456 (+10.04%) |
Filing |
| 2024-02-07 1:40 pm Purchase |
2023-12-31 | 13G | CYTEIR THERAPEUTICS INC CYTT |
BML Investment Partners L.P. | 3,470,008 9.600% |
734,035 (+26.83%) |
Filing |
| 2023-01-26 4:01 pm Purchase |
2023-01-20 | 13G | CYTEIR THERAPEUTICS INC CYTT |
BML Investment Partners L.P. | 2,735,973 7.700% |
2,735,973 (New Position) |
Filing |